Novartis AG Common Stock (NVS)
Interest Expense
$1.39B
TTM · Period ending: · USD
NVS Interest Expense
Latest reported$1.39Bperiod ending
Latest reported$1.39Bperiod ending
NVS TTM Interest Expense ($0.00 → $1.39B)
TTM interest expense
High-resolution chart · PNG
NVS interest expense history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Interest Expense (USD) |
|---|---|
| 1,390,294,000 | |
| 1,221,618,000 | |
| 1,148,839,000 | |
| 1,117,915,000 | |
| 1,103,792,000 | |
| 1,055,769,000 | |
| 1,005,291,000 | |
| 971,106,000 | |
| 926,229,000 | |
| 896,462,000 | |
| 877,185,650 | |
| 879,690,650 | |
| 863,690,650 | |
| 849,839,650 | |
| 850,373,000 | |
| 815,000,000 | |
| 811,000,000 | |
| 810,000,000 | |
| 811,000,000 | |
| 806,000,000 | |
| 813,000,000 | |
| 832,000,000 | |
| 869,000,000 | |
| 872,074,000 | |
| 879,074,000 | |
| 864,074,000 | |
| 851,074,000 | |
| 894,728,252 | |
| 907,728,252 | |
| 939,728,252 | |
| 931,728,252 | |
| 892,000,000 | |
| 860,000,000 | |
| 815,000,000 | |
| 777,000,000 | |
| 737,000,000 | |
| 714,000,000 | |
| 702,000,000 | |
| 707,000,000 | |
| 663,000,000 | |
| 643,000,000 | |
| 627,000,000 | |
| 621,000,000 | |
| 651,000,000 | |
| 679,000,000 | |
| 681,000,000 | |
| 670,000,000 | |
| 679,000,000 | |
| 667,000,000 | |
| 676,000,000 | |
| 683,000,000 | |
| 719,000,000 | |
| 727,000,000 | |
| 735,000,000 | |
| 724,000,000 | |
| 699,000,000 | |
| 719,000,000 | |
| 726,000,000 | |
| 751,000,000 | |
| 773,000,000 | |
| 763,000,000 | |
| 748,000,000 | |
| 692,000,000 | |
| 652,000,000 | |
| 637,000,000 | |
| 598,000,000 | |
| 551,000,000 | |
| 395,000,000 | |
| 318,000,000 | |
| 243,000,000 | |
| 157,000,000 | |
| 157,000,000 | |
| 61,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |